JJ PHARMA CONSULT ApS: Financial statements 2022
CVR: 33257635
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -19,376 and a net result of DKK 479,708 compared with DKK -592,952 the year before. Equity in the 2022 report amounted to DKK 2,357,769. The solvency ratio was 99.4%.
- Gross Profit
- DKK -19,376
- Profit/Loss
- DKK 479,708
- Equity
- DKK 2,357,769
- Total Assets
- DKK 2,370,869
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -19 t. | 480 t. | 2.4 mio. | 0 |
| 2021 | - | -14 t. | -593 t. | 2 mio. | - |
| 2020 | - | -20 t. | 1 mio. | 2.7 mio. | - |
| 2019 | - | -22 t. | -27 t. | 1.8 mio. | - |
| 2018 | - | -40 t. | -43 t. | 2 mio. | 0 |
Official annual report
Keep an eye on JJ PHARMA CONSULT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
JJ PHARMA CONSULT ApS has published its annual report for 2021. Gross profit came to DKK -14,419, and the net result was DKK -592,952.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity in the 2025 report amounted to DKK 16,917,153.